MA Boston의 소세포 폐암 임상 시험
소세포 폐암 관련 연구 21개가 Boston 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
피험자 모집 중2상
- Dana-Farber Cancer Institute /ID# 277732, Boston
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
피험자 모집 중1/2상
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
피험자 모집 중1상
- Dana Farber Cancer Institute, Boston
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
피험자 모집 중1/2상
- Tufts Medical Center, Boston
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
피험자 모집 중3상
- Dana-Farber Cancer Institute /ID# 279690, Boston
Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
피험자 모집 중1상
- Massachusetts General Hospital, Boston
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
피험자 모집 중1상
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
피험자 모집 중1/2상
- Dana Farber Cancer Institute ( Site 1105), Boston
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
피험자 모집 중1/2상
- Avenzo Therapeutics Recruiting Site, Boston
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
피험자 모집 중1/2상
- Dana Farber Cancer Institute, Boston
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
피험자 모집 중2상
- Beth Israel Deaconess Medical Center, Boston
- Dana Farber Cancer Institute, Boston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
피험자 모집 중1/2상
- Massachusetts General Hospital Cancer Center, Boston
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
피험자 모집 중3상
- Dana-Farber Cancer Institute, Boston
Study of NMS-03305293 in Adult Patient With Relapsed Small Cell Lung Cancer
피험자 모집 중1상
- Massachusetts General Hospital, Boston
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
피험자 모집 중1상
- Beth Israel Deaconess Medical Center, Boston
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
피험자 모집 중1/2상
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer
피험자 모집 중2상
- Dana Farber Cancer Institute, Boston
A Study of LY4175408 in Participants With Advanced Cancer
피험자 모집 중1상
- Massachusetts General Hospital, Boston
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
피험자 모집 중2상
- Tufts Medical Center, Boston
Biology of Young Lung Cancer Study: The YOUNG LUNG Study
피험자 모집 중관찰 연구
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
- Brigham and Women's Hospital, Boston
- 외 1개
DNA Analysis of Blood and Tissue from Patients with Lung Cancer
피험자 모집 중관찰 연구건강한 지원자 환영
- Massachusetts General Hospital, Boston
- Harvard School of Public Health, Boston
다른 도시의 소세포 폐암 시험
- Houston, TX연구 26개
- Arlington, VA연구 23개
- New York City, NY연구 21개
- Nashville, TN연구 20개
- Los Angeles, CA연구 20개
- Orlando, FL연구 15개
- Dallas, TX연구 13개
- St. Louis, MO연구 13개
- Cleveland, OH연구 13개
- Detroit, MI연구 12개
- Chicago, IL연구 12개
- Washington, DC연구 12개
Boston의 다른 연구
- 유방암연구 111개
- 비소세포폐암연구 90개
- 암 (전체)연구 86개
- 대장직장암연구 63개
- 전이성 암연구 63개
- 폐암연구 62개
- 난소암연구 61개
- 전립선암연구 59개
- 우울증연구 52개
- 자궁내막암연구 50개
- 심부전연구 44개
- 급성 골수성 백혈병연구 44개
ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.